Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Total Voting Rights

30 Apr 2018 16:30

RNS Number : 5810M
Swallowfield PLC
30 April 2018
 

Swallowfield plc

 

("Swallowfield" or the "Company")

 

Total voting rights

 

The Company's total issued share capital consists of 17,135,542 ordinary shares of 5 pence each ("Ordinary Shares") with one voting right per share. The Company does not hold any Ordinary Shares in treasury.

Therefore, the total number of voting rights in the Company is 17,135,542.

The above figure of 17,135,542 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

Swallowfield plc

Chris How

 Chief Executive Officer

 01823 662 241

Matthew Gazzard

 Group Finance Director

 01823 662 241

 

 

 

 

 

 

Alex Price

 N+1 Singer

 0207 496 3000

Jen Boorer

 

 

 

 

 

Josh Royston

 Alma PR

 0208 004 4218

Hilary Buchanan

 

 

Sam Modlin

 

 

 

 

 

 

About Swallowfield plc

 

Swallowfield plc is a market leader in the development, formulation, and supply of personal care and beauty products, whose customers include many of the world's leading brands.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRFBLFXVZFBBBZ
Date   Source Headline
25th Feb 20107:00 amRNSHalf Yearly Report
19th Feb 20102:31 pmRNSHolding(s) in Company
27th Jan 201012:29 pmRNSHolding(s) in Company
3rd Dec 20093:20 pmRNSDirectorate Change
18th Nov 20094:28 pmRNSHolding(s) in Company
13th Nov 20093:17 pmRNSHolding(s) in Company
5th Nov 20093:28 pmRNSAGM Statement
3rd Nov 200912:05 pmRNSDirectorate Change
27th Oct 20094:33 pmRNSTotal Voting Rights
15th Oct 20092:06 pmRNSExercise of options and Directors' dealing
8th Oct 20094:37 pmRNSPosting of Annual Report and Accounts
10th Sep 20097:00 amRNSFinal Results
26th Feb 20097:00 amRNSHalf Yearly Report
12th Jan 20097:00 amRNSChange of Adviser
24th Nov 20084:24 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSAGM Statement
16th Oct 20081:50 pmRNSHolding(s) in Company
13th Oct 20084:41 pmRNSAnnual Report and Accounts
13th Oct 200810:13 amRNSDirectorate Change
17th Sep 200811:15 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSDirector/PDMR Shareholding
11th Sep 20087:00 amRNSFinal Results
5th Sep 200810:00 amRNSNotice of Results
15th Jul 20087:00 amRNSRe Joint Venture
2nd Jun 200812:07 pmRNSHolding(s) in Company
28th Feb 20087:01 amRNSInterim Results
15th Jan 200811:36 amRNSHolding(s) in Company
11th Jan 20087:01 amRNSNew Cosmetics Operation
10th Jan 20083:49 pmRNSDirector/PDMR Shareholding
7th Jan 200810:34 amRNSDirector/PDMR Shareholding
28th Dec 200711:38 amRNSSale and Leaseback
8th Nov 20072:43 pmRNSAGM Statement
7th Nov 20074:10 pmRNSHolding(s) in Company
2nd Nov 20075:31 pmRNSre nomination of directors
2nd Nov 20077:00 amPRNStatement re nomination of new Swallowfield directors
17th Oct 200711:33 amRNSDirector/PDMR Shareholding
16th Oct 20073:30 pmRNSAnnual Report and Accounts
15th Oct 20077:01 amRNSDirectorate Change
12th Oct 20073:48 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSFinal Results
5th Sep 200710:29 amRNSHolding(s) in Company
17th Aug 20074:46 pmRNSAIM Rule 26
15th Jun 20073:45 pmRNSHolding(s) in Company
6th Jun 20077:01 amRNSTrading Statement
18th May 20074:29 pmRNSHolding(s) in Company
17th May 200712:21 pmRNSTrading Update
23rd Apr 200710:56 amRNSHolding(s) in Company
13th Apr 20072:47 pmRNSHolding(s) in Company
2nd Mar 20077:30 amRNSInterim Results
6th Feb 200712:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.